EXH5:XETRA:XETRA-iShares STOXX Europe 600 Insurance UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 40.46

Change

-0.34 (-0.82)%

Market Cap

USD 0.30B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B

ETFs Containing EXH5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.51% 82% B 80% B-
Dividend Return 3.66% 92% A 76% C+
Total Return 21.17% 91% A- 88% B+
Trailing 12 Months  
Capital Gain 25.50% 78% C+ 77% C+
Dividend Return 4.34% 92% A 78% C+
Total Return 29.83% 87% B+ 84% B
Trailing 5 Years  
Capital Gain 38.21% 54% F 57% F
Dividend Return 13.98% 95% A 69% C-
Total Return 52.19% 66% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.43% N/A N/A 64% D
Dividend Return 10.87% N/A N/A 70% C-
Total Return 2.44% N/A N/A 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 14.73% N/A N/A 49% F
Risk Adjusted Return 73.77% N/A N/A 77% C+
Market Capitalization 0.30B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike